Cancer
Oncology is the study of cancer, dedicated to its investigation, diagnosis, and treatment. Oncologists focus on the diagnosis and treatment of cancer, and also contribute to cancer research. Commonly, three types of oncologists are distinguished: medical, surgical and radiation.
Oncology is one of Johnson & Johnson's areas of expertise. Our goal is to make cancer not only manageable but also, one day, curable, by developing transformational and targeted treatment solutions that improve lives and enable those affected by cancer to enjoy more of life’s meaningful moments.
At Johnson & Johnson, we focus on cancer subtypes we know best, so that our deep expertise and experience can create the highest impact in terms of finding a cure and transforming the lives of people with cancer for the better.
Our best chance of achieving this focused, long-term commitment is with the help of ground-breaking technological advances and carefully selected partners across the globe.
Through our discovery, development and collaboration efforts, we continue to advance a comprehensive, differentiated portfolio and pipeline of small molecules, biologics and cell therapies for patients with haematological malignancies, prostate cancer, lung cancer and bladder cancer.
Introducing ‘Tasting Notes:’ nutrition support for those undergoing cancer treatment
We know that your taste can sometimes change whilst undergoing cancer treatment. This new site is here to support you with educational videos addressing challenges you may encounter alongside plenty of tips and new recipes. The information will help you experiment with food while adjusting to taste changes.
Explore our disease areas
Bladder cancer is a common form of cancer. In 2022, there were over 600,000 new cases of bladder cancer globally with Europe accounting for slightly more than 220,000 cases in men and women combined. Bladder cancer occurs when the cells that make up the urinary bladder begin to grow uncontrollably. The most common form of bladder cancer is urothelial carcinoma, also known as transitional cell carcinoma (TCC), which starts from the urothelial cells that line the inside of the bladder. Other forms of bladder cancer can develop elsewhere in the urinary tract, but these are all much less common.
Lung cancer is one of the most common types of cancer, accounting for more than 484,000 annual cancer diagnoses in Europe alone. In lung cancer, abnormal cells cluster together in the lungs, which can make you feel tired and breathless, and can cause chest pain and persistent coughs.
Prostate cancer is a type of cancer that develops in the prostate gland, located just behind the bladder. Each year, approximately 473,000 people in Europe are diagnosed with the condition, and it is now the second commonest cause of male cancer death. Most people with early-stage prostate cancer are asymptomatic. Screening for prostate cancer can play an important role in improving men's understanding of their health as part of an informed decision-making process with health care professionals.
